Wilfried Posch

[Wilfried Posch @WPosch]

New review spotlights HOCl as a safe, powerful antiseptic for nasal sprays & inhalation—potentially aiding against SARS-CoV-2 & flu. Precise dosing & strong trials needed. https://t.co/OYHhxpy0nT #mdpiviruses via @VirusesMDPI @Mic_Winter

[Wilfried Posch @WPosch]

Grateful to announce that the Austrian Science Fund and the Land Tyrol have granted my project: "How Cellular Complement Shapes Immunity via Dendritic Cells upon HIV infection."

@imed_tweets @FWF_at @unserlandtirol @HivResearch @EFIS_Immunology

[Wilfried Posch @WPosch]

@VetmeduniVienna Herzlichen Glückwunsch!!!

[Vetmeduni @VetmeduniVienna]

Wir freuen uns über die Verstärkung in unserer Professor:innenschaft und sagen: ❤-lich willkommen an der Vetmeduni 😊👏
→ Doris Wilflingseder, Professorin für Infektiologie
→ Katarzyna Sitnik, Assistenzprofessorin für "Virologie – Mechanismen und Dynamik viraler Infektionen"

[Wilfried Posch @WPosch]

Very glad that our Review on human respiratory 🫁 3D models and infection is online now:

Thank you @DorisWilflings1 @EurJImmunol @imed_tweets @EFIS_Immunology @y_efis

https://t.co/wY3maNT1xT

[Microbiology Spectrum @JournalSpectrum]

Personalized immune protective effects against novel SARS-CoV-2 variants of concern can be studied in human 3D respiratory models. These revealed major importance of salivary protection against different Omicron subvariants @WPosch https://t.co/rzN9t5lR9x

[Wilfried Posch @WPosch]

https://t.co/laeIuBIExA

[Wilfried Posch @WPosch]

Really glad to present our new data at this year’s DÖAK in Bonn #doeak #imed_tweets #HIV #AIDS #science

[Wilfried Posch @WPosch]

FDA no longer needs to require animal tests before human drug trials https://t.co/QTUtPjYrMh

[John Topham @John_P_Topham]

Interesting that ChAdOx1 showed long lasting protection
https://t.co/8AUATcRoH6

[Wilfried Posch @WPosch]

Austrian Society of Allergology and Immunology at the MESIA2022 in Prague @EFIS_Immunology @y_efis @NImmunologists

[Wilfried Posch @WPosch]

Our newest work published on neutralization against SARS-CoV-2 variants @imed_tweets
Serum neutralization against SARS-CoV-2 variants is heterogenic and depends on vaccination regimen https://t.co/uflq7eF8PQ

[Wilfried Posch @WPosch]

Has the ‘great resignation’ hit academia? https://t.co/NDzS9MuooT

[Wilfried Posch @WPosch]

@PeterWilleit @imed_tweets @ForscheninTirol @FWF_at @ORF @TTNachrichten Vielen Dank! 😊

[Wilfried Posch @WPosch]

Vielen Dank an die Prof. Brandl Stiftung für diese tolle Auszeichnung! @imed_tweets @ForscheninTirol @WPosch @FWF_at @ORF @TTNachrichten

[Wilfried Posch @WPosch]

@imed_tweets @jacionline Herzlichen Glückwunsch!!!!

[Kemper Complement Lab @CKemperLab]

The @KeystoneSymp Innate Immunity: Complement and Beyond has finally started here in beautiful Snowbird. Looking forward to three wonderful days filled with exciting new insights into complement research! #KSINNATECOMP22 #Complementbiology

[Kemper Complement Lab @CKemperLab]

#KSINNATECOMP22 in full swing! Fantastic talks on Complement and Beyond in infection + autoimmunity by Antonio Gregorio Dias Junior @GregorioDias1,Xiaoyu Zhao @zhaoxyu6,Wilfried Posch @WPosch, Alexandra Lucas, Elisabeth De Leeuw, Hrishikesh Kulkarni @hskulkarni and Daniel Seiler!

[Wilfried Posch @WPosch]

My research is available on @ResearchGate: https://t.co/RYMe9DJ7iF

[analytica @analyticaFair]

Meistgelesene analytica-News:
#COVID19 Simulation in der #3D Zellkultur 🧫 Neue Angriffsstrategien im Immunsystem
[German content]
https://t.co/1Ql7wwdJTL
@imed_tweets @WPosch @DorisWilflings1
#analytik #medizin #mikrobiologie #immunologie #coronavirus #SARSCoV2 #COVID19